Papers
10
Total Citations
182
H-Index
8
About
Lorenzo Livi is a distinguished radiation oncologist whose research has significantly advanced the field of stereotactic body radiotherapy (SBRT) and robotic radiosurgery, with a particular focus on applying precision radiation techniques to challenging clinical scenarios. His work spans a broad range of malignancies, including prostate cancer, breast cancer, liver oligometastases, cardiac tumors, and abdominal lymph node disease. Livi has been instrumental in establishing the clinical utility of CyberKnife-based robotic radiosurgery, demonstrating its efficacy in recurrent and oligometastatic settings where conventional approaches fall short. His 2017 study on robotic stereotactic retreatment for recurrent prostate cancer, garnering 50 citations, stands as a landmark contribution to salvage radiotherapy. Equally notable is his leadership of the phase II ROCK trial, exploring innovative preoperative radiosurgery for early breast cancer—a paradigm-shifting approach in breast cancer management. Beyond clinical outcomes, Livi has advanced treatment planning methodology, investigating complexity metrics and optimization strategies for MLC-based robotic plans, ensuring both technical rigor and patient safety. His cumulative body of work, spanning over a decade, has helped define best practices in stereotactic radiotherapy and continues to inspire researchers and clinicians pursuing high-precision, minimally invasive cancer treatment solutions.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Stereotactic Body Radiotherapy with Cyberknife for Cardiac Malignancies23 citations · 2015
- 4
- 5
- 6
- 7Robotic MLC‐based plans: A study of plan complexity11 citations · 2020
- 8
- 9ADAM phantom to test 4D medical imaging and dose delivery devices8 citations · 2019
- 10